share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K:外國發行人報告
美股SEC公告 ·  04/19 05:27
牛牛AI助理已提取核心訊息
Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.
Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.
Bruush口腔護理公司在提交給SEC的6-K文件中報告稱,由於一名董事於2023年4月12日從審計委員會辭職,公司目前不符合納斯達克審計委員會的要求。公司已被賦予到2024年4月12日恢復合規的時間,但未能做到。Kia Besharat於2024年4月10日辭去審計委員會主席和委員,因未達到獨立要求,儘管他仍是董事會的獨立董事。Bruush口腔護理公司已請求與納斯達克聽證小組進行聽證以上訴其證券退市的決定,聽證將於2024年4月25日舉行。公司於2024年4月15日收到通知,稱其不合規是退市的另一個基礎。公司已向小組提交了一份合規計劃,但無法保證小組的決定。
Bruush口腔護理公司在提交給SEC的6-K文件中報告稱,由於一名董事於2023年4月12日從審計委員會辭職,公司目前不符合納斯達克審計委員會的要求。公司已被賦予到2024年4月12日恢復合規的時間,但未能做到。Kia Besharat於2024年4月10日辭去審計委員會主席和委員,因未達到獨立要求,儘管他仍是董事會的獨立董事。Bruush口腔護理公司已請求與納斯達克聽證小組進行聽證以上訴其證券退市的決定,聽證將於2024年4月25日舉行。公司於2024年4月15日收到通知,稱其不合規是退市的另一個基礎。公司已向小組提交了一份合規計劃,但無法保證小組的決定。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。